DUBLIN, November 26, 2021 / PRNewswire / – “Global Nasal Spray Market 2021-2028” report has been added to ResearchAndMarkets.com offer.

This report indicates that the global nasal sprays market is expected to grow at a CAGR of 8.47% from 2021 to 2028.

Factors such as the emerging intranasal vaccines for COVID-19, the growing acceptance of self-administration of drugs, and the increasing use of nasal sprays are driving the growth of the studied market around the world. Moreover, the application of nasal sprays in the treatment of depression creates a lot of opportunities for the nasal sprays market.

Conversely, complications due to excessive use of nasal sprays have a negative impact on the overall development of the world market.

The global nasal spray market covers North America, Asia Pacific, Latin America, Europe, Middle East and Africa Regions.

Overall, the Asia Pacific is expected to experience the fastest growing nasal spray market during the estimated phase. In recent years, allergic diseases have dramatically increased in the region due to extensive urbanization and increasing environmental pollution. In addition, the most common causes of respiratory morbidity are smoking, infections and air pollution. Some of the major respiratory illnesses include tuberculosis and occupational lung disease. Such factors have influenced the adoption of nasal spray among the population, leading to the growth of the nasal spray market in APAC region.

Well-known companies in the nasal spray market are Sun Pharmaceuticals Industries Ltd, Johnson and Johnson, Novartis International AG, Sanotize Research and Development, Bharat Biotech, Viatris, Akorn, GlaxoSmithKline, Proctor and Gamble Co, Pfizer Inc, Catalent Inc, Cipla Limited, Allergan, Apotex Inc and Teva Pharmaceutical Industries Ltd.

Johnson and Johnson is involved in the R&D, manufacturing and sales of various products in the healthcare industry. Its business segment includes consumer, pharmaceutical and medical devices. The pharmaceutical segment provides products related to immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension and metabolism. In addition, the company operates in various regions, including Europe, the Middle East and Africa, the Asia Pacific, and Latin America. It has its seat at New Jersey, United States.

Main topics covered:

1. Global Nasal Spray Market – Summary

2. Industry outlook
2.1. Impact of Covid-19 on the Nasal Spray market
2.2. Key ideas
2.2.1. Allergy Treatments With Nasal Sprays
2.2.2. Using a nasal spray for diabetes
2.2.3. Treatment of endometriosis with nasal sprays
2.3. Porter’s Five Forces Analysis
2.3.1. The threat of new participants
2.3.2. The threat of substitutes
2.3.3. The bargaining power of buyers
2.3.4. Bargaining power of suppliers
2.3.5. Threat of competitive rivalry
2.4. Market attractiveness index
2.5. Supplier scorecard
2.6. Key market strategies
2.6.1. Mergers and Acquisitions
2.6.2. Contracts and Agreements
2.6.3. Disposals
2.7. Market factors
2.7.1. Emerging intranasal vaccines against Covid-19
2.7.2. Growing acceptance of self-administration of medications
2.7.3. Growing use of nasal sprays due to simple administration techniques
2.8. Market challenges
2.8.1. Complications from excessive use of nasal sprays
2.9. Market opportunities
2.9.1. Application of nasal sprays in the treatment of depression
2.9.2. Use of intranasal treatments for central nervous system disorders
2.9.3. Using the nasal spray as a vaccine

3. Global Nasal Spray Market Outlook – By Type
3.1. Nasal Spray Decongestion
3.2. Steroid nasal spray
3.3. Salt water solution / saline nasal spray

4. Global Nasal Spray Market Outlook – By Prescription
4.1. Over the counter
4.2. Prescribed

5. Global Nasal Spray Market Outlook – By Therapeutics
5.1. Antihistamine
5.2. Nasal steroids
5.3. Anticholinergic
5.4. Mast cell inhibitor

6. Global Nasal Spray Market Outlook – By Application
6.1. Nasal congestion
6.2. Allergic and non-allergic rhinitis
6.3. Vaccination
6.4. CNS disorders
6.5. Other applications

7. Global Nasal Spray Market Outlook – By End User
7.1. Home care environment
7.2. Asc / Clinics
7.3. Pharmacy
7.4. Hospital
7.5. Other end users

8. Global Nasal Spray Market – Regional Outlook

9. Competitive landscape
9.1. Akorn
9.2. Allergan
9.3. Apotex Inc
9.4. Bharat Biotech
9.5. Catalent Inc
9.6. Cipla Limited
9.7. GlaxoSmithKline
9.8. Johnson and Johnson
9.9. Novartis International SA
9.10. Pfizer Inc
9.11. Proctor and Gamble Co
9.12. Sanotize research and development
9.13. Sun Pharmaceuticals Industries Ltd
9.14. Teva Pharmaceutical Industries Ltd.
9.15. Viatris

10. Methodology and scope of the research

For more information on this report, visit https://www.researchandmarkets.com/r/1vzamz

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links